A detailed history of Royal Bank Of Canada transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 3,219 shares of AKYA stock, worth $9,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,219
Previous 2,799 15.01%
Holding current value
$9,753
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.96 - $2.94 $823 - $1,234
420 Added 15.01%
3,219 $8,000
Q2 2024

Aug 14, 2024

BUY
$1.94 - $4.56 $3,410 - $8,016
1,758 Added 168.88%
2,799 $6,000
Q1 2024

Nov 05, 2024

SELL
$4.33 - $6.06 $7,612 - $10,653
-1,758 Reduced 62.81%
1,041 $4,000
Q1 2024

May 15, 2024

SELL
$4.33 - $6.06 $30,405 - $42,553
-7,022 Reduced 87.09%
1,041 $4,000
Q4 2023

Feb 14, 2024

BUY
$3.13 - $5.13 $15,355 - $25,167
4,906 Added 155.4%
8,063 $39,000
Q3 2023

Nov 14, 2023

BUY
$4.24 - $7.44 $7,309 - $12,826
1,724 Added 120.31%
3,157 $14,000
Q2 2023

Aug 14, 2023

BUY
$5.28 - $8.35 $1,140 - $1,803
216 Added 17.75%
1,433 $10,000
Q1 2023

May 15, 2023

SELL
$7.6 - $12.68 $9,705 - $16,192
-1,277 Reduced 51.2%
1,217 $9,000
Q4 2022

Feb 14, 2023

BUY
$8.6 - $14.1 $16,959 - $27,805
1,972 Added 377.78%
2,494 $23,000
Q3 2022

Nov 14, 2022

BUY
$10.63 - $15.76 $1,094 - $1,623
103 Added 24.58%
522 $6,000
Q2 2022

Aug 15, 2022

SELL
$8.38 - $12.85 $6,159 - $9,444
-735 Reduced 63.69%
419 $5,000
Q1 2022

May 16, 2022

SELL
$9.84 - $14.97 $15,930 - $24,236
-1,619 Reduced 58.38%
1,154 $12,000
Q4 2021

Feb 14, 2022

BUY
$11.37 - $15.31 $19,431 - $26,164
1,709 Added 160.62%
2,773 $42,000
Q3 2021

Nov 15, 2021

BUY
$13.04 - $21.0 $7,054 - $11,361
541 Added 103.44%
1,064 $14,000
Q2 2021

Aug 16, 2021

BUY
$17.89 - $26.05 $9,356 - $13,624
523 New
523 $10,000

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $115M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.